浙江震元表示，上述项目的建成实施，一方面确保震元的拳头产品"原料药—制剂"产业链更为完整，显 著增强公司核心竞争力；另一方面，充分发挥公司在"合成生物学"新工艺技术优势，提升产品质量的同 时发挥规模优势，并在源头上降低传统药物生产工艺对生态环境的不良影响。 每经记者｜黄鑫磊 每经编辑｜陈俊杰 10月21日，合成生物概念股浙江震元（000705.SZ，股价9.81元，市值32.78亿元）公告称，当天公司召 开董事会及监事会会议，审议通过了相关议案，同意公司终止本次向特定对象发行股票事项并撤回申请 文件。 据悉，该发行事项自2024年4月启动，历经深交所受理、问询回复、延长决议有效期等多个环节，但综 合考虑当前资本市场环境以及公司整体发展规划等因素而终止。浙江震元表示，后续将合理利用自有及 自筹资金，保障本次募投项目顺利实施。 原计划募资4.95亿元 浙江震元此前披露的《2024年度向特定对象发行股票预案》显示，公司原计划通过募资4.95亿元，聚焦 医药工业核心项目建设，具体包括原料药集聚提升项目与上虞产业化基地项目。 其中，"浙江震元制药有限公司原料药集聚提升项目"投资总额4.81亿元，拟使用募集资金金额1.9 ...

Group 1: Financial Performance - The company achieved operating revenue of 5.981 billion yuan and a net profit attributable to shareholders of 19.1256 million yuan in the first half of 2025 [1] - The net cash flow from operating activities was 637 million yuan during the same period [1] Group 2: Business Segments - The clean energy business faced declining sales prices and gross margins, negatively impacting overall performance [1] - The semiconductor display materials business, particularly liquid crystal products, reached historical highs in production and sales, significantly enhancing profitability [1] - The life sciences business focused on green manufacturing and health products, with online sales revenue increasing by 70% year-on-year and offline sales revenue rising by 12% [4] Group 3: Strategic Initiatives - The company is implementing the "Chengzhi 2.0" strategic plan, focusing on high-end semiconductor display materials, chemical new materials, and synthetic biology [1] - Nanjing Chengzhi is optimizing its sales strategy to enhance economic benefits amid challenging market conditions for methanol and olefin products [2] - Chengzhi Yongqing is adjusting its sales strategy to counteract market price pressures by promoting contract sales and expanding into new markets [2] Group 4: Market Position and Innovation - Shijiazhuang Chengzhi Yonghua is a leading manufacturer in the liquid crystal materials sector, focusing on innovation and maintaining market leadership despite intense competition [3] - The company has increased its market share and reported over 30% year-on-year growth in sales revenue and net profit for TFT-LCD liquid crystal materials [3]